Latest round: Series B. Daniel Passeri is the President and CEO of Cue Biopharma, a biotechnology company focused on developing novel immunotherapies.
Daniel Passeri is the President and CEO of Cue Biopharma, a biotechnology company focused on developing novel immunotherapies for cancer and autoimmune diseases. He leads the company's strategic direction and operations as part of its executive leadership team.
Full founder directory · Investor directory · Company funding database · Fundraising library